BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31064849)

  • 1. PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.
    Kaminski L; Torrino S; Dufies M; Djabari Z; Haider R; Roustan FR; Jaune E; Laurent K; Nottet N; Michiels JF; Gesson M; Rocchi S; Mazure NM; Durand M; Tanti JF; Ambrosetti D; Clavel S; Ben-Sahra I; Bost F
    Cancer Res; 2019 Jul; 79(13):3268-3280. PubMed ID: 31064849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.
    Valcarcel-Jimenez L; Macchia A; Crosas-Molist E; Schaub-Clerigué A; Camacho L; Martín-Martín N; Cicogna P; Viera-Bardón C; Fernández-Ruiz S; Rodriguez-Hernandez I; Hermanova I; Astobiza I; Cortazar AR; Corres-Mendizabal J; Gomez-Muñoz A; Sanz-Moreno V; Torrano V; Carracedo A
    Cancer Res; 2019 Dec; 79(24):6153-6165. PubMed ID: 31594836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC1α drives a metabolic block on prostate cancer progression.
    Wallace M; Metallo CM
    Nat Cell Biol; 2016 May; 18(6):589-90. PubMed ID: 27230528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect.
    Dan Li ; Wang C; Ma P; Yu Q; Gu M; Dong L; Jiang W; Pan S; Xie C; Han J; Lan Y; Sun J; Sheng P; Liu K; Wu Y; Liu L; Ma Y; Jiang H
    Cell Death Dis; 2018 May; 9(5):466. PubMed ID: 29700317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
    Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
    Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
    Li J; Li Y; Chen L; Yu B; Xue Y; Guo R; Su J; Liu Y; Sun L
    Mol Med Rep; 2020 Jul; 22(1):155-164. PubMed ID: 32377739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
    Torrano V; Valcarcel-Jimenez L; Cortazar AR; Liu X; Urosevic J; Castillo-Martin M; Fernández-Ruiz S; Morciano G; Caro-Maldonado A; Guiu M; Zúñiga-García P; Graupera M; Bellmunt A; Pandya P; Lorente M; Martín-Martín N; Sutherland JD; Sanchez-Mosquera P; Bozal-Basterra L; Zabala-Letona A; Arruabarrena-Aristorena A; Berenguer A; Embade N; Ugalde-Olano A; Lacasa-Viscasillas I; Loizaga-Iriarte A; Unda-Urzaiz M; Schultz N; Aransay AM; Sanz-Moreno V; Barrio R; Velasco G; Pinton P; Cordon-Cardo C; Locasale JW; Gomis RR; Carracedo A
    Nat Cell Biol; 2016 Jun; 18(6):645-656. PubMed ID: 27214280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
    Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
    Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
    Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
    Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2.
    Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
    Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
    Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
    Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis.
    Trubiani O; Pieri C; Rapino M; Di Primio R
    Cell Prolif; 1999; 32(2-3):119-29. PubMed ID: 10535358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
    Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
    Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.
    Sarveswaran S; Ghosh R; Parikh R; Ghosh J
    Mol Cancer Ther; 2016 Nov; 15(11):2791-2801. PubMed ID: 27474149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.
    Tan Z; Luo X; Xiao L; Tang M; Bode AM; Dong Z; Cao Y
    Mol Cancer Ther; 2016 May; 15(5):774-82. PubMed ID: 27197257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics.
    Zhu Y; Piao C; Zhang Z; Jiang Y; Kong C
    Genomics; 2022 Jan; 114(1):125-137. PubMed ID: 34843906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.